The global Ventricular Assist Device market gathered revenue around USD 2.0 Billion in 2020 and market is set to grow USD 8.1 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 18.0% during the prediction period 2021 to 2027.
Growth Factors:
The rapidly growing global geriatric population is susceptible to chronic medical ailments such as diabetes, neurological disorders, cardiovascular diseases, stroke, and end-stage cardiac failure. The rising risks of organ failures and the growing demand for organ transplants due to these chronic ailments are contributing to the growth of the market for Ventricular Assist Devices (VADs). The development of innovative products and sophisticated miniature devices incorporated with features, such as infection control techniques, is expected to provide an impetus to the growth. The numerous benefits associated with the use of VADs, such as increased survival rate, durability, and functionality, are supporting the growing rate of adoption, and thereby boosting the market for VAD.
The growing rate of globalization, increasing pursual of unhealthy lifestyle habits, minimal physical activity, increased consumption of junk food and beverages, and tobacco and alcohol consumption if leading to the high global prevalence of cardiovascular diseases. The prevalence of rising cardiovascular diseases has been witnessed in developed countries of North America and Europe. Congenital heart diseases, heart failure, hypertension, ventricular septal defect, and stroke are among the major cardiovascular diseases. According to the CDC, in September 2020, nearly 7.0% or 19.0 million adults have critical congenital artery disease, and it has been estimated that approximately 2 in 10 adults aged 65 and below are likely to die from this disease.
In addition, the demand for VADs is primarily driven by the increasing prevalence of congenital heart disease, especially cyanotic congenital heart disease in adults. As per multiple population studies on heart failure and stroke, it has been recorded 65-70% of the cases are due to left ventricular systole dysfunction, which is boosting demand for ventricular assist devices. As per VAD procedure data it has been witnessed that hospitalization, in-hospital mortality, and hospital expenses have declined with the use of VAD. As per the American Heart Association estimates, U.S. annually spends USD 26 billion on heart failure patients.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Ventricular Assist Device market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Ventricular Assist Device market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
Report Scope | Details |
Market Size | USD 8.1 Billion by 2027 |
Growth Rate | CAGR of 18.0% From 2021 to 2027 |
Base Year | 2020 |
Forecast Period | 2021 to 2027 |
Historic Data | 2017 to 2020 |
Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
Segments Covered | Product, type of flow, design, application And Region |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Companies Mentioned | Abiomed; Medtronic; Abbott; Berlin Heart; Cardiac Assist, Inc.; Jarvik Heart, Inc.; ReliantHeart, Inc.; Sun Medical Technology Research Corp. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Ventricular Assist Device market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Regional analysis:
North America dominated the ventricular assist devices market and accounted for the largest revenue share of 53.2% in 2020. The availability of regulated reimbursement policies and coverages, increasing awareness regarding VADs such as bridge-to-recovery, destination therapies, and bridge-to-transplant are anticipated to drive the market for VAD in the forthcoming years. U.S population accounts for the highest number of obese citizens, making them susceptible to cardiovascular diseases. Furthermore, the development of technologically developed healthcare facilities in the U.S. is expected to drive the treatment numbers and provide impetus to market growth. The presence of favorable reimbursement policies and insurance coverages reducing out-of-pocket expenditure is expected to boost growth by supporting the rising treatment rate.
In Asia Pacific, the market for VAD is anticipated to witness the highest CAGR of 20.1% over the forecast period owing to the advancement in healthcare facilities and favorable government strategies such as the “Make in India” movement to boost private and public partnerships in India. Similarly, favorable initiatives in other Southeast Asian countries undertaken by public and private players are expected to drive Asia Pacific growth. Moreover, the rising medical tourism market in Asia Pacific providing high-quality and cost-effective treatment services is boosting regional growth.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Ventricular Assist Device Market include: Abiomed; Medtronic; Abbott; Berlin Heart; Cardiac Assist, Inc.; Jarvik Heart, Inc.; ReliantHeart, Inc.; Sun Medical Technology Research Corp.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Ventricular Assist Device market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Ventricular Assist Device market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Ventricular Assist Device markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Ventricular Assist Device market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Ventricular Assist Device Market, By Product
7.1. Ventricular Assist Device Market, By Product, 2021-2027
7.1.1. Left Ventricular Assist Device
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Right Ventricular Assist Device
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Bi-Ventricular Assist Device
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Total Artificial Heart
7.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Ventricular Assist Device Market, By Type Of Flow
8.1. Ventricular Assist Device Market, By Type Of Flow, 2021-2027
8.1.1. Pulsatile Flow
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Continuous Flow
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Ventricular Assist Device Market, By Application
9.1. Ventricular Assist Device Market, By Application, 2021-2027
9.1.1. Bridge to Transplant
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Destination Therapy
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Others (Bridge to Recovery, Bridge to Candidacy, and Others)
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Ventricular Assist Device Market, By Design
10.1. Ventricular Assist Device Market, By Design, 2021-2027
10.1.1. Implantable Ventricular Assist Device
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Transcutaneous Ventricular Assist Device
10.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 11.Global Ventricular Assist Device Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.1.3. Market Revenue and Forecast, By Application (2016-2027)
11.1.4. Market Revenue and Forecast, By Design (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.5.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.1.5.3. Market Revenue and Forecast, By Application (2016-2027)
11.1.5.4. Market Revenue and Forecast, By Design (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.6.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.1.6.3. Market Revenue and Forecast, By Application (2016-2027)
11.1.6.4. Market Revenue and Forecast, By Design (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.2.3. Market Revenue and Forecast, By Application (2016-2027)
11.2.4. Market Revenue and Forecast, By Design (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.5.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.2.5.3. Market Revenue and Forecast, By Application (2016-2027)
11.2.5.4. Market Revenue and Forecast, By Design (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Product(2016-2027)
11.2.6.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.2.6.3. Market Revenue and Forecast, By Application (2016-2027)
11.2.6.4. Market Revenue and Forecast, By Design (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.7.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.2.7.3. Market Revenue and Forecast, By Application (2016-2027)
11.2.7.4. Market Revenue and Forecast, By Design (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.8.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.2.8.3. Market Revenue and Forecast, By Application (2016-2027)
11.2.8.4. Market Revenue and Forecast, By Design (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.3.3. Market Revenue and Forecast, By Application (2016-2027)
11.3.4. Market Revenue and Forecast, By Design (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.5.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.3.5.3. Market Revenue and Forecast, By Application (2016-2027)
11.3.5.4. Market Revenue and Forecast, By Design (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.6.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.3.6.3. Market Revenue and Forecast, By Application (2016-2027)
11.3.6.4. Market Revenue and Forecast, By Design (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.7.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.3.7.3. Market Revenue and Forecast, By Application (2016-2027)
11.3.7.4. Market Revenue and Forecast, By Design (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.8.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.3.8.3. Market Revenue and Forecast, By Application (2016-2027)
11.3.8.4. Market Revenue and Forecast, By Design (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.4.3. Market Revenue and Forecast, By Application (2016-2027)
11.4.4. Market Revenue and Forecast, By Design (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.5.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.4.5.3. Market Revenue and Forecast, By Application (2016-2027)
11.4.5.4. Market Revenue and Forecast, By Design (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.6.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.4.6.3. Market Revenue and Forecast, By Application (2016-2027)
11.4.6.4. Market Revenue and Forecast, By Design (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.7.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.4.7.3. Market Revenue and Forecast, By Application (2016-2027)
11.4.7.4. Market Revenue and Forecast, By Design (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.8.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.4.8.3. Market Revenue and Forecast, By Application (2016-2027)
11.4.8.4. Market Revenue and Forecast, By Design (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.5.3. Market Revenue and Forecast, By Application (2016-2027)
11.5.4. Market Revenue and Forecast, By Design (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.5.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.5.5.3. Market Revenue and Forecast, By Application (2016-2027)
11.5.5.4. Market Revenue and Forecast, By Design (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.6.2. Market Revenue and Forecast, By Type Of Flow (2016-2027)
11.5.6.3. Market Revenue and Forecast, By Application (2016-2027)
11.5.6.4. Market Revenue and Forecast, By Design (2016-2027)
Chapter 12. Company Profiles
12.1. Abiomed
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Medtronic
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Abbott
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Berlin Heart
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Cardiac Assist, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Jarvik Heart, Inc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. ReliantHeart, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Sun Medical Technology Research Corp.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms